135 related articles for article (PubMed ID: 18607166)
1. Plasma N-epsilon-(carboxymethyl)lysine levels are associated with the extent of vessel injury after coronary arterial stenting.
Basta G; Berti S; Cocci F; Lazzerini G; Parri S; Papa A; Battaglia D; Lubrano V; Del Turco S; Ravani M; Rizza A; De Caterina R; Marraccini P; Mazzone A
Coron Artery Dis; 2008 Aug; 19(5):299-305. PubMed ID: 18607166
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
[TBL] [Abstract][Full Text] [Related]
3. High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis.
Basta G; Castagnini M; Del Turco S; Epistolato MC; Righini P; Sangiorgi GM; De Caterina R; Tanganelli P
Eur J Clin Invest; 2009 Dec; 39(12):1065-72. PubMed ID: 19811526
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina.
Ortolani P; Marzocchi A; Marrozzini C; Palmerini T; Aquilina M; Corlianò L; Saia F; Taglieri N; Sbarzaglia P; Bacchi Reggiani ML; Branzi A
Ital Heart J; 2004 Mar; 5(3):189-96. PubMed ID: 15119501
[TBL] [Abstract][Full Text] [Related]
5. Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.
Nienhuis HL; de Leeuw K; Bijzet J; Smit A; Schalkwijk CG; Graaff R; Kallenberg CG; Bijl M
Rheumatology (Oxford); 2008 Oct; 47(10):1554-8. PubMed ID: 18701539
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
7. Severity of diabetic microvascular complications is associated with a low soluble RAGE level.
Grossin N; Wautier MP; Meas T; Guillausseau PJ; Massin P; Wautier JL
Diabetes Metab; 2008 Sep; 34(4 Pt 1):392-5. PubMed ID: 18701333
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory markers and coronary interventions: a potentially useful follow-up modality after stenting.
Patti G; Di Sciascio G; D'Ambrosio A; Dicuonzo G; Abbate A; Dobrina A
Catheter Cardiovasc Interv; 2002 Jul; 56(3):341-5. PubMed ID: 12112886
[TBL] [Abstract][Full Text] [Related]
9. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
[TBL] [Abstract][Full Text] [Related]
10. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
[TBL] [Abstract][Full Text] [Related]
11. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic value of advanced glycation end-products in chronic heart failure.
Hartog JW; Voors AA; Schalkwijk CG; Scheijen J; Smilde TD; Damman K; Bakker SJ; Smit AJ; van Veldhuisen DJ
Eur Heart J; 2007 Dec; 28(23):2879-85. PubMed ID: 17986469
[TBL] [Abstract][Full Text] [Related]
13. Acute neutrophil activation in direct stenting: comparison of stable and unstable angina patients.
Gach O; Nys M; Deby-Dupont G; Chapelle JP; Lamy M; Piérard LA; Legrand V
Int J Cardiol; 2006 Sep; 112(1):59-65. PubMed ID: 16316691
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.
Falcone C; Emanuele E; D'Angelo A; Buzzi MP; Belvito C; Cuccia M; Geroldi D
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1032-7. PubMed ID: 15731496
[TBL] [Abstract][Full Text] [Related]
15. Decreased plasma sRAGE levels in COPD: influence of oxygen therapy.
Gopal P; Rutten EP; Dentener MA; Wouters EF; Reynaert NL
Eur J Clin Invest; 2012 Aug; 42(8):807-14. PubMed ID: 22288943
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
[TBL] [Abstract][Full Text] [Related]
17. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
Sebeková K; Somoza V; Jarcusková M; Heidland A; Podracká L
Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732
[TBL] [Abstract][Full Text] [Related]
18. The effect of percutaneous coronary intervention on inflammatory response and endothelial progenitor cell recruitment.
Garg R; Tellez A; Alviar C; Granada J; Kleiman NS; Lev EI
Catheter Cardiovasc Interv; 2008 Aug; 72(2):205-9. PubMed ID: 18651648
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of early inflammatory response after sirolimus-eluting stent vs bare metal stent implantation in native coronary lesions.
Li JJ; Qin XW; Yang XC; Li ZC; Zeng HS; Xu B; Gao Z; Wu YJ; Zhang X; Zhang CY
Clin Chim Acta; 2008 Oct; 396(1-2):38-42. PubMed ID: 18634770
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical outcome of coronary artery stenting or coronary artery bypass grafting in patients with multiple-vessel disease.
Kohsaka S; Goto M; Virani S; Lee VV; Aoki N; Elayda MA; Reul RM; Wilson JM
J Thorac Cardiovasc Surg; 2008 Aug; 136(2):500-6. PubMed ID: 18692664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
